There are dividends about at the moment. Time to reinvest them as all are running scared.
Disclaimer:
As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. The author may own shares in any companies discussed, all opinions are his/her own & are general/impersonal. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.
BT Group plc is a communications services company. The Company is engaged in providing and managing data and voice networks and providing a range of services over these networks. It operates in approximately 170 countries worldwide. The Company is a principal communications services provider, selling products and services to consumers, small and medium-sized enterprises and the public sector. The Company also sells wholesale products and services to communications providers in the United Kingdom and around the world. The Company supplies managed networked information technology (IT) services to multinational corporations, domestic businesses and national and local government organizations. Bt has four lines of business: BT Global Services, BT Retail, BT Wholesale and Openreach. In December 2012, the Company sold of its remaining 9.1% iin Tech Mahindra Ltd to institutional investors. more »
GlaxoSmithKline plc (GSK) is global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical products include medicines in therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and human immunodeficiency virus (HIV). The Company operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. On January 30, 2013, GSK acquired additional 29.3% interest in GlaxoSmithKline Consumer Healthcare Ltd. In May 2013, GlaxoSmithKline PLC acquired Okairos AG. more »
